compounded versions available through some licensed pharmacies but the FDA has specifically cautioned against compounded BPC-157 citing immune reaction risk and inadequate safety data
Our Business G&L offers four key services across a variety of sectors
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
This information is educational only and not intended as medical advice
One of the most frequently searched questions in research settings is: How do you reconstitute BPC-157? This guide explains the general laboratory process , using examples with 5 mg and 10 mg vials
Use our Peptide Calculator to determine the precise volume of water and concentration for your research protocol